18 résultats avec le mot-clé: 'dendrogenin synergizes cytarabine acute myeloid leukemia cells vitro'
In addition, to trigger cancer cell re-differentiation, longer exposure times or µ M concentrations of DDA induced cell death in cancer cells of various tissue origins
N/A
ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; B-ALL, B-cell acute lymphoblastic leukemia; BAT, Bispecific antibody armed activated T-cells; BCMA, B-cell
N/A
18 Table 2: Expression of IL-3Rα and β chains on primary malignant cells from patients suffering from BPDCN, acute myeloid leukemia (AML) cells, acute lymphoid leukemia
N/A
Keywords: lipid nanocapsules, acute myeloid leukemia, decitabine, nanomedicine, nanopar- ticles, oral administration, Caco2
N/A
Primary AML cells treated with DDA–idarubicin showed a massive accumulation of cytoplasmic macrovesicles visualized by MGG staining (Figure 4 B) and increased in MOLM-14, OCI-AML3
N/A
MDS, myelodysplastic syndrome; AML, acute myeloid leukemia; CLL, chronic lymphocytic leukemia; MM, multiple myeloma; CML, chronic myelogenous leukemia; ALL, acute
N/A
Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia,.. 82 Myelodysplastic Syndromes, and Acute
N/A
ACKR3, atypical chemokine receptor 3; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CFP, cyan fluorescent protein; CNS, central nervous
N/A
polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia. Prognostic significance ofthe null genotype of glutathione S-transferase-T1 in patients with acute
N/A
Abbreviations: ALWP, Acute leukemia working party; AML, Acute myeloid leukemia; ATT, Average treatment effect among the treated; auto-HSCT, Autologous stem cell transplantation;
N/A
ALL: Acute lymphoblastic leukemia; AML: Acute myeloid leukemia; ATG: Anti- thymocyte globulin; CB: Umbilical cord blood; CBT: Umbilical cord blood transplantation; CI:
N/A
ALL: Acute lymphoblastic leukemia; AML: Acute myeloid leukemia; ATG: Anti- thymocyte globulin; CB: Umbilical cord blood; CBT: Umbilical cord blood transplantation; CI:
N/A
Umbilical cord blood versus unrelated donor transplantation in adults with primary refractory or relapsed acute myeloid leukemia: a report from Eurocord, the Acute Leukemia
N/A
Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With NPM1 Mutation: A Study by the Acute
N/A
Intravenous busulfan compared with treosulfan-based conditioning for allogeneic stem cell transplantation in acute myeloid leukemia: a study on behalf of the acute leukemia
N/A
Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells - high expression is associated with adverse prognosis as well as altered
N/A
The impact of graft-versus-host disease prophylaxis in reduced- intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia
N/A